Undisclosed AMD Program

About Character Biosciences

Character Biosciences is a private, clinical-stage biotech company pioneering a data-driven approach to treat complex polygenic diseases. By integrating genomics, longitudinal clinical data, imaging, and AI, the company identifies patient subtypes and genetic drivers of disease progression to develop more precise therapeutics. The company has built a robust pipeline with candidates in Phase 1 for dry AMD and geographic atrophy, secured Series B funding from top-tier investors, and assembled a seasoned leadership team with expertise in drug discovery, data science, and clinical development.

Therapeutic Areas

Other Age-Related Macular Degeneration (AMD) Drugs